Literature DB >> 1452657

Baculovirus expression of the nucleoprotein gene of measles virus and utility of the recombinant protein in diagnostic enzyme immunoassays.

K B Hummel1, D D Erdman, J Heath, W J Bellini.   

Abstract

A recombinant baculovirus that expresses the nucleoprotein gene of measles virus (Edmonston vaccine strain) under the transcriptional control of the polyhedrin promoter was generated. The expressed protein (B-MVN) comigrated with the authentic viral nucleoprotein as observed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and it was phosphorylated. The B-MVN protein proved to be reactive with monoclonal antibodies in radioimmunoprecipitations, and it was immunogenic, eliciting in mice antisera that recognized the native nucleoprotein. In addition, the B-MVN protein was evaluated as a replacement source of antigen for whole virus in enzyme immunoassays (EIAs) for detection of measles virus-specific immunoglobulin M (IgM) and IgG antibodies. A capture IgM EIA with the B-MVN protein as antigen detected specific IgM antibodies in 18 (72%) acute- and all convalescent-phase specimens from 25 clinical measles cases and exceeded 99% specificity with 120 control specimens. An indirect IgG EIA with the B-MVN protein detected specific IgG antibodies in 129 of 131 (98%) serum specimens with antibodies to measles virus, and results obtained from testing 268 additional serum specimens were better correlated with measles virus-neutralizing antibodies than those obtained with a commercial EIA.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1452657      PMCID: PMC270545          DOI: 10.1128/jcm.30.11.2874-2880.1992

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  15 in total

1.  Fluorescent antibody studies with agents of varicella and herpes zoster propagated in vitro.

Authors:  T H WELLER; A H COONS
Journal:  Proc Soc Exp Biol Med       Date:  1954 Aug-Sep

2.  Measles antibody: reevaluation of protective titers.

Authors:  R T Chen; L E Markowitz; P Albrecht; J A Stewart; L M Mofenson; S R Preblud; W A Orenstein
Journal:  J Infect Dis       Date:  1990-11       Impact factor: 5.226

3.  Encapsidation of Sendai virus genome RNAs by purified NP protein during in vitro replication.

Authors:  S C Baker; S A Moyer
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

4.  The plaque-neutralization test as a measure of prior exposure to measles virus.

Authors:  W A Orenstein; P Albrecht; K L Herrmann; R Bernier; K J Bart; E Z Rovira
Journal:  J Infect Dis       Date:  1987-01       Impact factor: 5.226

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Evaluation of the structural proteins of the hamster neurotropic strain of measles virus with monoclonal antibodies.

Authors:  W Bellini; G Englund; K Rammohan; D E McFarlin
Journal:  J Neuroimmunol       Date:  1986-04       Impact factor: 3.478

7.  Evaluation of monoclonal antibody-based capture enzyme immunoassays for detection of specific antibodies to measles virus.

Authors:  D D Erdman; L J Anderson; D R Adams; J A Stewart; L E Markowitz; W J Bellini
Journal:  J Clin Microbiol       Date:  1991-07       Impact factor: 5.948

8.  Role of virus strain in conventional and enhanced measles plaque neutralization test.

Authors:  P Albrecht; K Herrmann; G R Burns
Journal:  J Virol Methods       Date:  1981-12       Impact factor: 2.014

9.  Antigenic analysis of African measles virus field isolates: identification and localisation of one conserved and two variable epitope sites on the NP protein.

Authors:  P Giraudon; M F Jacquier; T F Wild
Journal:  Virus Res       Date:  1988-05       Impact factor: 3.303

10.  Measles virus nucleocapsid protein protects rats from encephalitis.

Authors:  B Bankamp; U G Brinckmann; A Reich; S Niewiesk; V ter Meulen; U G Liebert
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

View more
  41 in total

1.  Measles immunization coverage determined by serology and immunization record from children in two Chicago communities.

Authors:  John T Watson; Enrique Ramirez; Anne Evens; William J Bellini; Hope Johnson; Julie Morita
Journal:  Public Health Rep       Date:  2006 May-Jun       Impact factor: 2.792

2.  Successful respiratory immunization with dry powder live-attenuated measles virus vaccine in rhesus macaques.

Authors:  Wen-Hsuan Lin; Diane E Griffin; Paul A Rota; Mark Papania; Stephen P Cape; David Bennett; Brian Quinn; Robert E Sievers; Charles Shermer; Kenneth Powell; Robert J Adams; Steven Godin; Scott Winston
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-31       Impact factor: 11.205

3.  Detection of RNA of mumps virus during an outbreak in a population with a high level of measles, mumps, and rubella vaccine coverage.

Authors:  Rebecca H Bitsko; Margaret M Cortese; Gustavo H Dayan; Paul A Rota; Luis Lowe; Susan C Iversen; William J Bellini
Journal:  J Clin Microbiol       Date:  2008-01-09       Impact factor: 5.948

4.  Estimates of mumps seroprevalence may be influenced by antibody specificity and serologic method.

Authors:  Donald R Latner; Marcia McGrew; Nobia J Williams; Sun B Sowers; William J Bellini; Carole J Hickman
Journal:  Clin Vaccine Immunol       Date:  2013-12-26

5.  A duplex recombinant viral nucleoprotein microbead immunoassay for simultaneous detection of seroresponses to human respiratory syncytial virus and metapneumovirus infections.

Authors:  Yange Zhang; W Abdullah Brooks; Doli Goswami; Mustafizur Rahman; Stephen P Luby; Dean D Erdman
Journal:  J Virol Methods       Date:  2014-05-23       Impact factor: 2.014

6.  Seroprevalence of chronic hepatitis B virus infection and immunity to measles, rubella, tetanus and diphtheria among schoolchildren aged 6-7 years old in the Solomon Islands, 2016.

Authors:  Lucy Breakwell; Jenniffer Anga; Gretchen Cooley; Laura Ropiti; Sarah Gwyn; Kathleen Wannemuehler; Joseph Woodring; Divinal Ogaoga; Diana Martin; Minal Patel; Rania A Tohme
Journal:  Vaccine       Date:  2020-05-28       Impact factor: 3.641

7.  Enzyme-linked immunospot assay detection of mumps-specific antibody-secreting B cells as an alternative method of laboratory diagnosis.

Authors:  Donald R Latner; Marcia McGrew; Nobia Williams; Luis Lowe; Roniel Werman; Eli Warnock; Kathleen Gallagher; Peter Doyle; Sandra Smole; Susan Lett; Noelle Cocoros; Alfred DeMaria; Raimond Konomi; Cedric J Brown; Paul A Rota; William J Bellini; Carole J Hickman
Journal:  Clin Vaccine Immunol       Date:  2010-11-03

8.  Rapid competitive enzyme-linked immunosorbent assay for detection of antibodies to peste des petits ruminants virus.

Authors:  Kang-Seuk Choi; Jin-Ju Nah; Young-Joon Ko; Shien-Young Kang; Nam-In Jo
Journal:  Clin Diagn Lab Immunol       Date:  2005-04

9.  Comparison of the sensitivity of laboratory diagnostic methods from a well-characterized outbreak of mumps in New York city in 2009.

Authors:  Jennifer S Rota; Jennifer B Rosen; Margaret K Doll; Rebecca J McNall; Marcia McGrew; Nobia Williams; Elena N Lopareva; Albert E Barskey; Amado Punsalang; Paul A Rota; William R Oleszko; Carole J Hickman; Christopher M Zimmerman; William J Bellini
Journal:  Clin Vaccine Immunol       Date:  2013-01-16

10.  Reliable confirmation of antibodies to bovine respiratory syncytial virus (BRSV) by enzyme-linked immunosorbent assay using BRSV nucleocapsid protein expressed in insect cells.

Authors:  S K Samal; M K Pastey; T McPhillips; D K Carmel; S B Mohanty
Journal:  J Clin Microbiol       Date:  1993-12       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.